FDA approves additional claim for Roche cobas Zika test

New claim allows for streamlined screening of pooled blood or plasma donations

Approved claim follows updated industry recommendations for screening the US blood supply for Zika virus

Zika virus infection is linked to neurological complications in ad... Diagnostics, FDA Roche Group, cobas Zika, Zika

Source: HSMN NewsFeed - May 14, 2018 Category: Pharmaceuticals Source Type: news